Tag: Respiratory Problems: Misc.
Some Immunosuppressed Do Not Have Anti-Spike Antibodies After COVID-19 Vaccination
IgG anti-spike antibodies undetectable in ~20 percent with immunosuppression who had received three or more COVID-19 vaccines
Poll: Only Half of Older Adults Have Heard of New RSV Vaccine
However, poll reveals that once aware of the vaccine, about two-thirds are interested in receiving it
FDA Approves RSV Vaccine for Pregnant Women to Help Protect Newborns
Abrysvo indicated to be given between 32 and 36 weeks of pregnancy to prevent lower respiratory tract disease caused by RSV in infants from birth through 6 months
E-Cigarette Use Tied to Respiratory Symptoms in Young Adults
Findings independent of combustible cannabis and cigarette exposures
Pediatricians’ Group Urges That All Infants Get New RSV Shot
The American Academy of Pediatrics recommendation applies to infants 19 months of age or younger
Most Infants With RSV-Related Critical Illness Born at Term
Risk for intubation higher for infants younger than 3 months, those born prematurely, publicly insured
Education on Approval Process May Increase Acceptance of New RSV Vaccines
Those educated on vaccine approval process or about potential severity of RSV may be more accepting
Study Looks at Impact of Low Vitamin K on Lung Function
Low vitamin K status linked to lower ventilatory capacity, increased odds of COPD, wheezing, asthma
CDC Recommends RSV Shot for All Infants
Vaccine has been shown to reduce the risk for both hospitalizations and health care visits for RSV in infants by about 80 percent
Study Explores Persons With Tobacco Exposure, Preserved Spirometry
No accelerated rate of decline in FEV1 or increased incidence of COPD seen in symptomatic TEPS versus asymptomatic, but more respiratory exacerbations
